In silico Investigation on Isatin (1H-indole-2,3-dione) Derivatives as Potential AntiTumor Necrosis Factor-Alpha

http://www.doi.org/10.26538/tjnpr/v6i11.21

Authors

  • Abel K. Oyebamiji Department of Chemistry and Industrial Chemistry, Bowen University, Iwo, Osun State, Nigeria.
  • Emmanuel T. Akintayo Department of Chemistry and Industrial Chemistry, Bowen University, Iwo, Osun State, Nigeria.
  • Banjo Semire omputational Chemistry Research Laboratory, Department of Pure and Applied Chemistry, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Oyo State, Nigeria.
  • Kehinde A. Odelade Department of Science Laboratory Technology, Federal Polytechnic, Ayede, Oyo state, Nigeria
  • Babatunde O. Adetuyi Department of Natural Sciences, Faculty of Pure and Applied Sciences, Precious Cornerstone University, Ibadan, Nigeria.
  • Amin Hafiz Department of Clinical Nutrition, Faculty of Applied Medical Sciences, Umm Al-Qura University, Kindom of Saudi Arabia.
  • Gaber E. Batiha Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, AlBeheira, Egypt

Keywords:

Inhibitory activity, Molecular docking, B3LYP, Binding Affinity, Cancer

Abstract

The role played by tumor necrosis factor-alpha (TNF-α) in advancing cancer has drawn the attention of many researchers. Thus, Isatin(1H-Indole-2,3-Dione) derivatives have been explored to curb this dreaded cancer-causing agent via semi-empirical (PM6) method. In order to obtain the descriptors that describe anti-tumor necrosis factor-alpha, the quantitative structure-activity relationship (QSAR) and molecular docking methods were used in this study. The ability of the studied compounds to acts as a drug were evaluated using Lipinski rule of five. The selected descriptors were used to develop QSAR model, which proved to be predictive, and this was confirmed and validated by considering the squared correlation coefficient (R2=0.89), adjusted squared correlation coefficient (adj. R2=0.89), cross validation (CV R2=0.87). The docked compounds 9, 14, and 16 against tumor necrosis factor-alpha (TNF-α) with -6.5 kcal/mol proved to be effective than other studied compounds as well as the referenced drug. Also, the correlation between the selected descriptors and calculated binding affinity was examined. It was observed that the plot of Log P against binding affinity obeyed 0.5≤x≤1, which showed that Log P contributed to inhibitory activities of the studied compounds against tumor necrosis
factor-alpha. 

References

Grabarek B, Bednarczyk M, Mazurek U. The characterization of tumor necrosis factor alpha (TNF-α), its role in cancerogenesis and cardiovascular system diseases and possibilities of using this cytokine as a molecular marker. Folia Biologica et Oecologica 2017; 13.

Uthansingh K, Pati GK, Parida PK, Narayan J, Pradhan S, Sahu MK, Padhy RN. Evaluation of Tumor Necrosis Factor-Alpha Gene (−308 G/A, −238 G/A and −857 C/T) Polymorphisms and the Risk of Gastric Cancer in Eastern Indian Population. Gastroenterol. Insights 2022; 13: 340–348

Li L, Liu J, Liu C, Lu X. The correlation between TNF-α-308 gene polymorphism and susceptibility to cervical cancer. Oncol. Lett. 2018; 15:7163–7167.

Georgios K, Robert S, Sabine K-K, Jurgen E. Ambivalent Effects of Tumor Necrosis Factor Alpha on Apoptosis of Malignant and Normal Human Keratinocytes. Skin Pharmacol Physiol. 2021; 34:94–102.

Kokolakis G, Bachmann F, Wolk K, Sabat R, Philipp S. Efficacy of adalimumab for nail psoriasis during 24 months of continuous therapy. Acta Derm Venereol. 2020; 100(14).

Sabat R, Jemec Gregor BE, Matusiak Ł, Kimball AB, Prens E, Wolk K, Hidradenitis suppurativa. Nat Rev Dis Primers. 2020; 6(1):18.

Ghoreschi K, Balato A, Enerbäck C, Sabat R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet. 2021.

Z. Tribak, Y. Kandri Rodi, Y. Kharbach, A. Haoudi, MK Skalli, A Mazzah, M Akhazzane and EM Essassi. Synthesis Of New 1h-Indole-2,3-Dione Derivatives Using Phase-Transfer Catalysis and Characterization By X-Ray Crystallography J. Mar. Chim. Heterocycl. 2016; 15(1):79-84.

Elkaeed EB, Yousef RG, Elkady H, Gobaara IMM, Alsfouk AA, Husein DZ, Ibrahim IM, Metwaly AM, Eissa IH. The Assessment of Anticancer and VEGFR-2 Inhibitory Activities of a New 1H-Indole Derivative: In Silico and In Vitro Approaches. Processes. 2022; 10:1391.

Bogdanov AV, Sirazieva AR, Voloshina AD, Abzalilov TA, Samorodov AV. Synthesis and Antimicrobial, Antiplatelet, and Anticoagulant Activities of New Isatin Deivatives Containing a Hetero-Fused Imidazole Fragment. Russ J Org Chem. 2022; 58:327–334.

Mondal P and Mondal S. Synthesis, characterization and SAR studies of Novel Series of Spiro β-Lactam of 5-methylindole- 2,3-dione derivatives as a potential antibacterial and anthelmintic agent. Curr Chem Letters. 2022; 11:403–414.

Kumar G , Singh NP, Kumar K. Recent Advancement of Synthesis of Isatins as a Versatile Pharmacophore: A review. Drug Res (Stuttg). 2021; 71(03):115-121.

Kumar S and Ritika A. brief review of the biological potential of indole derivatives. Futur J Pharm Sci. 2020; 6.

Ozdarska K, Petremant M, Wu K-C, Bourguet E. Synthesis of novel pyridazino[1,6-a]indole-2,4(1H,3H)-dione and pyridazino[1,6-a]indol-2(1H)-one via intramolecular electrophilic aromatic substitution. Results in Chem. 2022; 4:100612.

Reem IA, Azza SZ, Mohamed IA. Synthesis, Spectroscopic Characterization and Antimicrobial Potential of Certain New Isatin-Indole Molecular Hybrids. Molecules 2017; 22:1958.

Oyebamiji AK, Josiah OM, Akintelu SA, Adeoye MD, Sabitu BO, Latona DF, Esan AO, Soetan EA, Semire B. Dataset on Insightful Bio-Evaluation of 2-(quinoline-4-yloxy)acetamide Analogues as Potential Anti-Mycobacterium tuberculosis Catalase-Peroxidase Agents Via In silico Mechanisms. Data in Brief, 2021.

Oyebamiji AK, Akintelu AS, Mutiu OA, Adeosun IJ, Kaka MO, Olotu TM, Soetan AE, Adelowo JM, Semire B. In-Silico Study on Anti-cancer Activity of Selected Alkaloids from Catharanthus roseus. Trop J Nat Prod Res. 2021; 5(7):1315- 1322.

Molly MH, Annemarie SS, Johan DO, William MF, Andrew CB, Adrian W, Mark TC, Jun W, Alexey AL, Josh CY, Amy DF, Graham F, John KE, Eric SD, Leslie AC, Teresa GC, Stephan KM, Jessica EF, Ingrid CC, Brian CC. Small-Molecule Inhibition of TNF-α. Science. 2005; 310(5750):1022-5.

Boukarai Y, Khalil F, Bouachrine M. QSAR study of isatin(1Hindole-2,3-dione) analogues as in vitro anti-cancer agents using the statistical analysis methods and the artificial neural network. Int J Sci & Eng Res. 2015; 6(11):159-166.

Semire B, Oyebamiji A & Odunola OA. Design of (2Z)-2- cyano-2-[2-[(E)-2-[5-[(E)-2-(4-dimethylaminophenyl)vinyl]-2- thienyl]vinyl]pyran-4-ylidene]acetic acid derivatives as D-p-A dye sensitizers in molecular photovoltaics: a density functional theory approach. Res on Chem Intermediates. 2016; 42:4605- 4619.

Semire B, Oyebamiji AK and Odunola OA. Tailoring of Energy Levels in (2Z)-2-cyano-2-[2-[(E)-2-[2-[(E)-2-(ptolyl)vinyl]thieno[3,2-b]thiophen-5-yl]vinyl]pyran-4- ylidene]acetic acid Derivatives via Conjugate Bridge and Fluorination of Acceptor units for Effective D-π-A DyeSensitized Solar Cells: DFT-TDDFT Approach, Res on Chem Intermediates. 2017; 43:1863–1879.

Olasupo SB, Uzairu A, Shallangwa G, Uba S. Quantitative structure-activity relationship (QSAR) studies and molecular docking simulation of norepinephrine transporter (NET) inhibitors as anti-psychotic therapeutic agents. J Turkish Chem Soc Sect A Chem. 2019; 7(1):179–196.

Oyebamiji AK, Fadare OA, Akintelu SA, Semire B. Biological Studies on Anthra[1,9-cd]pyrazol-6(2D)-one Analogues as Anti-vascular Endothelial Growth Factor Via In silico Mechanisms. Chem Afr. 2021; 4(4):955-963.

Adeoye MD, Olarinoye EF, Oyebamiji AK, Latona DF. Theoretical Evaluation of Potential Anti-Alanine Dehydrogenase Activities of Acetamide Derivatives. Biointerface Res in Appl Chem. 2022; 12(6):7469–7477.

Downloads

Published

2022-11-01

How to Cite

Oyebamiji, A. K., Akintayo, E. T., Semire, B., Odelade, K. A., Adetuyi, B. O., Hafiz, A., & Batiha, G. E. (2022). In silico Investigation on Isatin (1H-indole-2,3-dione) Derivatives as Potential AntiTumor Necrosis Factor-Alpha: http://www.doi.org/10.26538/tjnpr/v6i11.21. Tropical Journal of Natural Product Research (TJNPR), 6(11), 1870–1875. Retrieved from https://tjnpr.org/index.php/home/article/view/1241

Most read articles by the same author(s)